Literature DB >> 11702879

Trilateral retinoblastoma variant indicative of the relevance of the retinoblastoma tumor-suppressor pathway to medulloblastomas in humans.

W J Elias1, M B Lopes, W L Golden, J A Jane, F Gonzalez-Fernandez.   

Abstract

Results of recent studies have led investigators to suggest that the retinoblastoma tumor-suppressor (rb) gene plays an underappreciated role in the genesis of brain tumors. Such tumors cause significant rates of mortality in children suffering from hereditary retinoblastoma. It has been assumed that the pineal gland, which is ontogenetically related to the retina, accounts for the intracranial origin of these trilateral neoplasms. To address this issue, the authors describe an unusual trilateral retinoblastoma variant. The authors provide a detailed clinicopathological correlation by describing the case of a child with bilateral retinoblastoma who died of a medulloblastoma. The intraocular and intracranial neoplasms were characterized by performing detailed imaging, histopathological, and postmortem studies. Karyotype analysis and fluorescence in situ hybridization were used to define the chromosomal defect carried by the patient and members of her family. An insertion of the q12.3q21.3 segment of chromosome 13 into chromosome 18 at band q23 was identified in members of the patient's family. This translocation was unbalanced in the proband. The intraocular and cerebellar neoplasms were found to be separate primary neoplasms. Furthermore, the pineal gland was normal and the cerebellar neoplasm arose within the vermis as a medulloblastoma. Finally, the two neoplasms had different and characteristically identifiable cytolological and immunohistochemical profiles. The findings of the present study, taken together with those of recent molecular and transgenic studies, support the emerging concept that rb inactivation is not restricted to central nervous system regions of photoreceptor lineage and that inactivation of this tumor suppressor pathway may be relevant to the determination of etiological factors leading to medulloblastoma in humans.

Entities:  

Mesh:

Year:  2001        PMID: 11702879     DOI: 10.3171/jns.2001.95.5.0871

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Trilateral retinoblastoma: A systematic review of 211 cases.

Authors:  Ryuya Yamanaka; Azusa Hayano; Yasuo Takashima
Journal:  Neurosurg Rev       Date:  2017-08-16       Impact factor: 3.042

2.  Diffusion characteristics of pediatric pineal tumors.

Authors:  Asim F Choudhri; Matthew T Whitehead; Adeel Siddiqui; Paul Klimo; Frederick A Boop
Journal:  Neuroradiol J       Date:  2015-05-11

Review 3.  Heterogeneity in retinoblastoma: a tale of molecules and models.

Authors:  Sonya Stenfelt; Maria K E Blixt; Charlotta All-Ericsson; Finn Hallböök; Henrik Boije
Journal:  Clin Transl Med       Date:  2017-11-09

4.  Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.

Authors:  Kathleen M Schieffer; Alexander Z Feldman; Esko A Kautto; Sean McGrath; Anthony R Miller; Maria Elena Hernandez-Gonzalez; Stephanie LaHaye; Katherine E Miller; Daniel C Koboldt; Patrick Brennan; Benjamin Kelly; Amy Wetzel; Vibhuti Agarwal; Margaret Shatara; Suzanne Conley; Diana P Rodriguez; Rolla Abu-Arja; Ala Shaikhkhalil; Matija Snuderl; Brent A Orr; Jonathan L Finlay; Diana S Osorio; Annie I Drapeau; Jeffrey R Leonard; Christopher R Pierson; Peter White; Vincent Magrini; Elaine R Mardis; Richard K Wilson; Catherine E Cottrell; Daniel R Boué
Journal:  Acta Neuropathol Commun       Date:  2021-04-07       Impact factor: 7.801

5.  Metachronous, non-pineal, trilateral retinoblastoma in a patient with a seemingly reduced-expressivity RB1 germline deletion.

Authors:  Saga Elise Eiset; Mikkel Funding; Hilary Racher; Steffen Heegaard; Brenda Gallie; Steen Fiil Urbak; Pernille A Gregersen
Journal:  Clin Case Rep       Date:  2022-03-18

6.  Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.

Authors:  Marcel Kool; Jan Koster; Jens Bunt; Nancy E Hasselt; Arjan Lakeman; Peter van Sluis; Dirk Troost; Netteke Schouten-van Meeteren; Huib N Caron; Jacqueline Cloos; Alan Mrsić; Bauke Ylstra; Wieslawa Grajkowska; Wolfgang Hartmann; Torsten Pietsch; David Ellison; Steven C Clifford; Rogier Versteeg
Journal:  PLoS One       Date:  2008-08-28       Impact factor: 3.240

7.  Development of zebrafish medulloblastoma-like PNET model by TALEN-mediated somatic gene inactivation.

Authors:  Jaegal Shim; Jung-Hwa Choi; Moon-Hak Park; Hyena Kim; Jong Hwan Kim; Seon-Young Kim; Dongwan Hong; Sunshin Kim; Ji Eun Lee; Cheol-Hee Kim; Jeong-Soo Lee; Young-Ki Bae
Journal:  Oncotarget       Date:  2017-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.